NCT05205863View on ClinicalTrials.gov

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 12, 2021

Primary Completion Date

August 20, 2022

Study Completion Date

September 3, 2022

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Cofact

Human prothrombin complex concentrate

Trial Locations (1)

Unknown

PRA Health Sciences, Groningen

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Prothya Biosolutions

INDUSTRY